KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Intangibles (2016 - 2025)

Historic Intangibles for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $9.2 billion.

  • Biogen's Intangibles fell 529.04% to $9.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.2 billion, marking a year-over-year decrease of 529.04%. This contributed to the annual value of $9.2 billion for FY2025, which is 529.04% down from last year.
  • As of Q4 2025, Biogen's Intangibles stood at $9.2 billion, which was down 529.04% from $9.3 billion recorded in Q3 2025.
  • Biogen's Intangibles' 5-year high stood at $9.8 billion during Q3 2024, with a 5-year trough of $1.8 billion in Q2 2023.
  • Its 5-year average for Intangibles is $5.5 billion, with a median of $5.2 billion in 2021.
  • Per our database at Business Quant, Biogen's Intangibles crashed by 3119.51% in 2021 and then surged by 36345.98% in 2024.
  • Over the past 5 years, Biogen's Intangibles (Quarter) stood at $2.2 billion in 2021, then decreased by 16.71% to $1.9 billion in 2022, then skyrocketed by 352.03% to $8.4 billion in 2023, then rose by 15.88% to $9.7 billion in 2024, then decreased by 5.29% to $9.2 billion in 2025.
  • Its last three reported values are $9.2 billion in Q4 2025, $9.3 billion for Q3 2025, and $9.5 billion during Q2 2025.